All In MedTech

Device Trial Radar · NCT05148156

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Reduction of Urinary Toxicity of Stereotactic Body Radiation Therapy (SBRT) With Prostatic Urethral Lift (Urolift)

Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

20

Planned (sponsor's estimate)

Start

Feb 11, 2026

Primary completion

Sep 2027

Study completion Mar 2028

Sponsor

Lead sponsor
Northwell HealthAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
NeoTract, Inc.; Teleflex
First posted
Dec 8, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 50 years, up to 99 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Many patients may face long-term urinary side effects following stereotactic body radiation therapy (SBRT), including increased urinary frequency, dysuria, and nocturia. The investigator hypothesizes that Urolift, which represents a novel minimally invasive therapy, may reduce acute and long-term urinary toxicity and side effects of radiation therapy (SBRT).

Conditions

  • Benign Prostatic Hyperplasia

Interventions

  • UroliftDevice

    Study intervention involves a one-time administration of Urolift in out-patient setting prior to Stereotactic body radiation therapy (SBRT).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in IPSS scores from baseline and one year post treatmentTime frame: At baseline and one year post treatment
  2. Change in IIEF score through study completion, an average of 1 yearTime frame: Through study completion, an average of 1 year
  3. Change in MSHQ through study completion, an average of 1 yearTime frame: Through study completion, an average of 1 year

3 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Northwell Health

    Syosset, New York · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.